$CELG Company News Higher rates are coming — here’s

New Post Public Reply Private Reply Replies (0) Message Board

May 15, 2014 at 10:11 AM

$CELG Company News

Higher rates are coming — here’s how you prepare 8:38 a.m. May 12, 2014 - Jeff Reeves
Wall Street up for second day on earnings cheer; biotechs rebound: Stock market live blog recap 4:03 p.m. April 29, 2014 - blogs.marketwatch.com
Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Sue Chang
What ‘Game of Thrones’ can teach you about money 8:30 a.m. April 5, 2014 - Wallace Witkowski
Biotechs, bonds and more from the 'tempest in a microsecond' 8:32 a.m. April 2, 2014 - Shawn Langlois
Play-it-safe stock investors may take some risk on jobs 8:31 a.m. March 30, 2014 - Wallace Witkowski
Nasdaq pullback rife with opportunity 2:07 p.m. March 25, 2014 - The Trading Deck
44 stocks on takeover target radar: Morgan Stanley 12:48 p.m. March 25, 2014 - blogs.marketwatch.com
Biotech comeback stalls as Wall Street starts to worry 12:45 p.m. March 25, 2014 - Russ Britt
Biotech has second straight sell-off; sector mutual funds take it on chin 10:40 a.m. March 24, 2014 - Russ Britt
Biotech's Friday selloff: Are sector bears growling or just stretching? 5:08 p.m. March 21, 2014 - Russ Britt
The Nasdaq has a message to deliver 1:57 p.m. March 20, 2014 - The Trading Deck
Aeropostale slides; Liberty Media drops Sirius plan 4:16 p.m. March 14, 2014 - Sue Chang
UK drug rejection, patent concerns take a bite out of Celgene shares 1:33 p.m. March 14, 2014 - Russ Britt
From every angle, technicals point to richer stocks 2:26 p.m. March 11, 2014 - The Trading Deck
Winning approval for new drugs may get harder, analyst warns 4:56 p.m. Feb. 28, 2014 - Russ Britt
The market puts a few feathers in its cap 2:58 p.m. Jan. 23, 2014 - The Trading Deck
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 5:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Celgene's 2014 guidance falls below analyst views 1:19 p.m. Jan. 13, 2014 - MarketWatch.com
Clovis Oncology, seen as 'next ICPT,' jumps 5% 10:47 a.m. Jan. 13, 2014 - Victor Reklaitis

Hottest Healthcare Stocks Now – HMSY CYH VRTX CELG 1:30 p.m. May 14, 2014 - InvestorPlace.com
Celgene Needs to Clear the Cluster Zone 9:00 a.m. May 14, 2014 - RealMoney.com
Prothena: 4 Different Insiders Have Purchased Shares This Month 11:42 a.m. May 13, 2014 - Seeking Alpha
3 Stocks Reiterated As A Buy: COP, CELG, BIIB 2:44 p.m. May 12, 2014 - TheStreet.com
Will Patterson (PDCO) Disappoint this Earnings Season? - Analyst Blog 1:00 p.m. May 12, 2014 - Zacks.com
Visualizing Biotech P/E Compression and Why It's a Buy Signal 10:19 a.m. May 12, 2014 - TheStreet.com
2014 FDA Drug Approval Calendar 9:22 a.m. May 12, 2014 - TheStreet.com
UPDATE: Morgan Stanley Reiterates On Celgene Ahead Of Markman Hearing 8:07 a.m. May 12, 2014 - benzinga.com
Investor's Corner: How To Use The Big Cap 20 3:09 p.m. May 8, 2014 - Investors Business Daily
3 Stocks Advancing The Drugs Industry 1:02 p.m. May 8, 2014 - TheStreet.com
RBC Doctor Panel Picks in Drugs and Biotech 7:54 a.m. May 8, 2014 - 247WallSt.com
Fear Not, Biotech Stock 'Correction' Is Not a Bursting Bubble 10:18 a.m. May 7, 2014 - TheStreet.com
What Does Celgene's May 15 Markman Hearing Mean to You? 10:11 a.m. May 7, 2014 - TheStreet.com
3 Stocks Reiterated As A Buy: MU, CAT, CELG 10:59 a.m. May 6, 2014 - TheStreet.com
Celgene: Do The Revlimid Polymorph And Use Patents Matter? 11:44 a.m. May 5, 2014 - Seeking Alpha
Biotech Sector Performance in April: Gilead Sciences Rising 9:49 a.m. May 2, 2014 - TheStreet.com
Health Care Stocks Still Healthy Despite Higher Hedging Costs 6:30 a.m. May 2, 2014 - TheStreet.com
Merrimack Pancreatic Cancer Treatment Shows Positive Results in Study 4:45 p.m. May 1, 2014 - The Wall Street Journal Interactive Edition
Biotech Stock Roundup: Gilead's Sovaldi Shines, Biogen & Alexion Up Outlook - Analyst Blog 10:55 a.m. April 30, 2014 - Zacks.com
Celgene Deal Chief Calls Big Pharma Gutless For Lack of Biotech M&A 4:26 p.m. April 29, 2014 - TheStreet.com

Celgene Announces Presentations of Investigational Studies in Solid Tumor and Blood Cancers at ASCO 2014 5:19 p.m. May 14, 2014 - BusinessWire - BZX
Critical Alerts For DirecTV, JPMorgan, First Solar, Celgene, and Baidu.com Released By InvestorsObserver 9:31 a.m. May 14, 2014 - PR Newswire - PRF
Clinical Trial Results, Acquisitions, Healthcare Partnership, and Pricing of Senior Notes - Analyst Notes on Merck, JNJ, Chelsea, Unitedhealth and Celgene 7:20 a.m. May 13, 2014 - PR Newswire - PRF
Celgene Prices $2.5 Billion of Senior Unsecured Notes 7:32 a.m. May 7, 2014 - BusinessWire - BZX
Technical Coverage on Biotech Stocks -- Research on Celgene, Cell Therapeutics, Geron, and BioMarin Pharma 9:15 a.m. May 6, 2014 - PR Newswire - PRF
Celgene Announces Offering of Senior Unsecured Notes 8:32 a.m. May 6, 2014 - BusinessWire - BZX
Quarterly Earnings Releases, Social Initiatives, and Upcoming Conferences - Analyst Notes on Merck, WellPoint, UnitedHealth, Forest and Celgene 8:00 a.m. May 5, 2014 - PR Newswire - PRF
New Drug Applications, Quarterly Results, and University Partnerships - Analyst Notes on Celgene, HCA, Thermo Fisher Scientific, Cubist and Agilent 8:00 a.m. May 2, 2014 - PR Newswire - PRF
Critical Alerts For Coca Cola, Baidu.com, Urban Outfitters, Celgene, and Trina Solar Released By InvestorsObserver 9:31 a.m. May 1, 2014 - PR Newswire - PRF
Celgene Corporation to Present at Investor Conferences in May 8:30 a.m. April 25, 2014 - BusinessWire - BZX
Drug Approvals, Quarterly Earnings Releases, and Stock Price Updates - Analyst Notes on Merck, Johnson & Johnson, UnitedHealth, Celgene and GW 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Celgene Acquires Late-Stage Product for Crohn’s Disease and Other Gastrointestinal Disorders 7:33 a.m. April 24, 2014 - BusinessWire - BZX
Upcoming Earnings Announcements -- Research on Superior Energy Services, Celgene, Penn National Gaming, and PerkinElmer 12:32 p.m. April 22, 2014 - PR Newswire - PRF
Healthcare Companies Report Product Availability, Earning Release Schedules, Event, and Stock Movements - Analyst Notes on Celgene, Vanda, Chelsea Therapeutics, Neurocrine Biosciences, and USANA 8:00 a.m. April 14, 2014 - PR Newswire - PRF
BlackBerry CEO May Consider Exiting Handset Business; Celgene Corporation Favored over Natco in Pre-trial 12:43 a.m. April 10, 2014 - ACCESSWIRE
Coverage of Biotech Equities -- Research on Arena Pharma, Celgene, PDL BioPharma, and Hemispherx Biopharma 1:20 p.m. April 8, 2014 - PR Newswire - PRF
Celgene Corporation Sued by Mylan Inc.; GRUBHUB Soars on its First Day of Trading 12:10 a.m. April 7, 2014 - ACCESSWIRE
BetterInvesting Magazine Releases June Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use 4:15 p.m. April 4, 2014 - PR Newswire - PRF
Healthcare Companies Report Transactions, Appeals, New Research Findings and Stock Movements - Analyst Notes on Johnson & Johnson, Teva, Celgene, Cara Therapeutics, and OncoMed Pharmaceuticals 8:00 a.m. April 3, 2014 - PR Newswire - PRF
Critical Alerts For News Corp, Gold SPDR, McDonalds, Trina Solar, and Celgene Released By InvestorsObserver 9:31 a.m. April 1, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

RARE Foundation Rebrands, Focus Still Strong

Unveiling the RARE Foundation's New Identity In the stock market, you ride waves of change, and let me tell you, it ain't just stocks and bonds that change names and faces. Case in point: The EveryLife Foundation for Rare Diseases has spiffed up as the RARE Foundation. New name, new logo, the whole enchilada. This isn't just a cosmetic touch-up, though. It's about...

Tampa General’s Innovation Excellence Earns No. 20 Spot

A Bold Leap into Innovation at Tampa General There's a heck of a lot going on down in Tampa that's worth more than just a golf clap. Tampa General Hospital (TGH) just snagged the 20th spot on Fast Company's Best Workplaces for Innovators list, and let me tell you, that’s no small feat amidst the heavy hitters in verticals like biotech and consumer goods. It takes guts...

Shareholder Rights in Focus: Examining Key Buyouts

Shareholder Concerns Rise Amid Corporate Buyouts The stakes are high for the shareholders of Distribution Solutions Group, Eagle Financial Services, Safety Insurance Group, and Utz Brands as their companies face potential buyouts. Let's chew over what's on the table: the sweet deals insiders might score and the legal maneuvers in play. Halper Sadeh LLC, a heavy-hitting...

Maurices Strengthens Position with Key Refinancing Deal

Maurices' Bold Financial Maneuver When a retailer like Maurices, with its near-century-long history, decides to play in the financial arena, it sure makes my ears perk up. This Duluth-based women's fashion retailer isn't just dipping its toes in—it's executing a full-blown refinancing blitzkrieg and coming out stronger. Announcing the completion of its refinancing plan...

Cap Juluca: Caribbean Luxury Redefined on Maundays Bay

The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...

Push Notification Security Transforms Healthcare IT Support

Cutting the Fat on IT Help Desk Bottlenecks Healthcare IT teams are fighting an uphill battle with password resets, a mundane task consuming up to half of all help desk calls. It's like trying to stop a leaking dam with duct tape. For health systems, these calls aren't just a minor annoyance—they're a full-fledged budget hog. Try telling a CIO that an agent-friendly...

Monib Zirvi's Dermatology Excellence Honored in 2026

Trailblazer in Dermatology Recognized Again Fancy yourself a star in dermatology? Well, take notes from Dr. Monib A. Zirvi. The guy just got his due recognition from Marquis Who's Who for his sizable contributions to dermatology and research. For someone who's been at this game for over two decades, Zirvi doesn't just glide by on old merits. He's the real deal, and his...

MCatalysis Secures $5M to Disrupt Fuel Cost Dynamics

Funding Fuels Innovation MCatalysis has just secured a hefty $5 million in seed funding to throw down with the big dogs in energy production. This isn't your regular backyard science project; this company is serious about changing the game with a tech-driven approach that could undercut current fuel prices. HL Energy Ventures and Oxford Science Enterprises are backing...

CUBEX Lights Up Veterinary Care with Mini Essential

Inventory Woes? Meet Mini Essential If you’ve ever worked in or around veterinary hospitals, you know the old-school headaches of managing controlled substances. Picture this: piles of paper logs, end-of-shift recounting, and inevitable discrepancies that rear their ugly heads long after closing time. Enter CUBEX, shaking things up with their latest launch, Mini...

Job Market Shifts: Adaptation vs. Fairness Dilemma

The Chameleon Effect in Today's Job Market Walk into any open-space office these days, and you'll see faces plastered with composed, work-ready smiles—faces that might not look so familiar outside those walls. The modern workplace has draped its cloak over individual personalities, with the mighty pressure to 'fit in' often forcing a change in how folks present...